Apellis eye drug likely to be rejected in Europe, company says
BioPharma
Source: biopharmadive.com
Stay updated with breaking news from Umer Raffat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Hello, and welcome to the Q3 2023 Teva Pharmaceutical Industries Limited Earnings Conference Call. My name is Alex. I'll be coordinating the call today.
Production 'largely unaffected' by Israel-Hamas war, drugmaker says
TEVA earnings call for the period ending September 30, 2023.
BIIB earnings call for the period ending September 30, 2023.